BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16647137)

  • 1. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
    Dschietzig T; Bartsch C; Baumann G; Stangl K
    Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts.
    Gabris-Weber B; Forghani R; Bernd Dschietzig T; Romero G; Salama G
    Biochem Pharmacol; 2024 May; 223():116136. PubMed ID: 38494063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs of the future: the hormone relaxin.
    Samuel CS; Hewitson TD; Unemori EN; Tang ML
    Cell Mol Life Sci; 2007 Jun; 64(12):1539-57. PubMed ID: 17458501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin inhibits early steps in vascular inflammation.
    Brecht A; Bartsch C; Baumann G; Stangl K; Dschietzig T
    Regul Pept; 2011 Jan; 166(1-3):76-82. PubMed ID: 20851151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges.
    Jung J; Han H
    Heliyon; 2024 Jan; 10(2):e24463. PubMed ID: 38298643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Factors Involved in the Reproductive Morphophysiology of Female Domestic Cat (
    Santos LC; Silva JF
    Animals (Basel); 2023 Oct; 13(19):. PubMed ID: 37835759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway.
    Sun A; Ye H; Xu Z; Chen J; Xiao W; Zhang T; Sha X; Bi S; Zhou T; Yang H
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism.
    Yuan S; Guo D; Liang X; Zhang L; Zhang Q; Xie D
    Front Cell Dev Biol; 2023; 11():1131481. PubMed ID: 37123405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Currently Selected Laboratory Animals Useful in the Research of How Female Hormones Influence Orthodontic Biomechanics?
    Peruga M; Kawala B; Sarul M; Kotowicz J; Lis J
    Animals (Basel); 2023 Feb; 13(4):. PubMed ID: 36830416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Mechanism of Sex Hormones on Sertoli Cell Development and Proliferation.
    Shah W; Khan R; Shah B; Khan A; Dil S; Liu W; Wen J; Jiang X
    Front Endocrinol (Lausanne); 2021; 12():648141. PubMed ID: 34367061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological Benefits and Risk of Using Hormones in Organ Perfusion and Preservation Solutions in the Aspect of Minimizing Hepatic Ischemia-Reperfusion Injury during Storage.
    Ostróżka-Cieślik A; Dolińska B
    Biomed Res Int; 2019; 2019():6467134. PubMed ID: 31828112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Relaxin Expression from an Alginate Gel-Encapsulated Adenovirus on Scar Remodeling in a Pig Model.
    Yun IS; Kang E; Ahn HM; Kim YO; Rah DK; Roh TS; Lee WJ; Yun CO
    Yonsei Med J; 2019 Sep; 60(9):854-863. PubMed ID: 31433583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF.
    Simon J; Nemeth E; Nemes A; Husveth-Toth M; Radovits T; Foldes G; Kiss L; Bagyura Z; Skopal J; Merkely B; Gara E
    Front Physiol; 2019; 10():690. PubMed ID: 31231242
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation.
    Meroni SB; Galardo MN; Rindone G; Gorga A; Riera MF; Cigorraga SB
    Front Endocrinol (Lausanne); 2019; 10():224. PubMed ID: 31040821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Birth and Neonatal Transition in the Guinea Pig: Experimental Approaches to Prevent Preterm Birth and Protect the Premature Fetus.
    Hirst JJ; Palliser HK; Shaw JC; Crombie G; Walker DW; Zakar T
    Front Physiol; 2018; 9():1802. PubMed ID: 30618814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects.
    Soubret A; Pang Y; Yu J; Dahlke M
    Br J Clin Pharmacol; 2018 Nov; 84(11):2572-2585. PubMed ID: 30014598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Relaxin Expressing Adenovirus on Scar Remodeling: A Preliminary Study.
    Jung BK; Lee WJ; Kang E; Ahn HM; Kim YO; Rah DK; Yun CO; Yun IS
    Arch Craniofac Surg; 2017 Mar; 18(1):9-15. PubMed ID: 28913296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.
    Wang D; Luo Y; Myakala K; Orlicky DJ; Dobrinskikh E; Wang X; Levi M
    Sci Rep; 2017 Aug; 7(1):9793. PubMed ID: 28851937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.